RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

Blade--your memory is fine. Mihael Polymeropoulos was at Novartis, and Vanda's Chairman Karabelas had a Novartis connection too. So they licensed iloperidone in a sweetheart 'alumni' deal--500K upfront,I believe.

In response to an earlier post, this is not a victory for biotech. This is the spawn of a BP, taking a BP drug ahead. Had they actually created a useful biomarker/test, that might have been a biotech contribution. But they put that aside, and just did the 'same old, same old.'

Thia will give aid and comfort to the me-too crowd, and take resources away from small company creativity.

NeuroInvestment